Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain shedding

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 11, 2010, Pages 1165-1180

  Mück, Christoph ^a   Herndler Brandstetter, Dietmar ^a   Micutkova, Lucia ^a   Grubeck Loebenstein, Beatrix ^a   Jansen Dürr, Pidder ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

CEP; Ectodomain shedding; HUVEC; Senescence; TL1A

Indexed keywords

BETA GALACTOSIDASE; DIPEPTIDE; HYDROXAMIC ACID; ISOPROTEIN; N ((2 (HYDROXYAMINOCARBONYL)METHYL) 4 METHYLPENTANOYL) 3 (2' NAPHTHYL)ALANYLALANINE, 2 AMINOETHYLAMIDE; N-((2-(HYDROXYAMINOCARBONYL)METHYL)-4-METHYLPENTANOYL)-3-(2'-NAPHTHYL)ALANYLALANINE, 2-AMINOETHYLAMIDE; TNFSF15 PROTEIN, HUMAN; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

APOPTOSIS; ARTICLE; CELL AGING; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; ELECTROPORATION; ENDOTHELIUM CELL; ESCHERICHIA COLI; HUMAN; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

APOPTOSIS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; DIPEPTIDES; ELECTROPORATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ESCHERICHIA COLI; HUMANS; HYDROXAMIC ACIDS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; UMBILICAL VEINS;

EID: 77958069021     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq129     Document Type: Article

References (70)

1. Campisi J, Sedivy J. How does proliferative homeostasis change with age? What causes it and how does it contribute to aging? J Gerontol A Biol Sci Med Sci. 2009;64:164-166.
2. Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004;114:1299-1307.
3. Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev. 2007;128:36-44.
4. Dimri GP, Lee X, Basile G, et al. A biomarker that identifes senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci \USA. 1995;92:9363-9367.
5. Ressler S, Bartkova J, Niederegger H, et al. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell. 2006;5:379-389.
6. Vasile E, Tomita Y, Brown LF, Kocher O, Dvorak HF. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 2001;15:458-466.
7. Melk A, Schmidt BM, Takeuchi O, Sawitzki B, Rayner DC, Halloran PF. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int. 2004;65: 510-520.
8. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation. 2002;105:1541-1544.
9. Chen J, Goligorsky MS. Premature senescence of endothelial cells: Methusaleh's dilemma. Am J Physiol Heart Circ Physiol. 2006;290: H1729-H1739.
10. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729-740.
11. Coppe JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6:2853-2868.
12. Kuilman T, Peeper DS. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer. 2009;9:81-94.
13. Maier JA, Voulalas P, Roeder D, Maciag T. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science. 1990;249:1570-1574.
14. Ferber A, Chang C, Sell C, et al. Failure of senescent human fbroblasts to express the insulin-like growth factor-1 gene. J Biol Chem. 1993;268:17883-17888.
15. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008;132:363-374.
16. Krizhanovsky V, Yon M, Dickins RA, et al. Senescence of activated stellate cells limits liver fbrosis. Cell. 2008;134:657-667.
17. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99-118.
18. Wang J, Jacob NK, Ladner KJ, et al. RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair. EMBO Rep. 2009;10:1272-1278.
19. Tan KB, Harrop J, Reddy M, et al. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene. 1997;204:35-46.
20. Zhai Y, Ni J, Jiang GW, et al. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J. 1999;13:181-189.
21. MigoneTS, Zhang J, LuoX, etal. TL1Ais a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity. 2002;16:479-492.
22. Ware CF. The TNF superfamily-2008. Cytokine Growth Factor Rev. 2008;19:183-186.
23. Chew LJ, Pan H, Yu J, et al. A novel secreted splice variant of vascular endothelial cell growth inhibitor. FASEB J. 2002;16:742-744.
24. Jin T, Guo F, Kim S, Howard A, Zhang YZ. X-ray crystal structure of TNF ligand family member TL1A at 2.1A. Biochem Biophys Res Commun. 2007;364:1-6.
25. Al-Lamki RS, Wang J, Tolkovsky AM, et al. TL1A both promotes and protects from renal infammation and injury. J Am Soc Nephrol. 2008;19:953-960.
26. Bamias G, Martin C III, Marini M, et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in infammatory bowel disease. J Immunol. 2003;171:4868-4874.
27. Kang YJ, Kim WJ, Bae HU, et al. Involvement of TL1A and DR3 in induction of pro-infammatory cytokines and matrix metalloproteinase-9 in atherogenesis. Cytokine. 2005;29:229-235.
28. Prehn JL, Mehdizadeh S, Landers CJ, et al. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal infammation. Clin Immunol. 2004;112:66-77.
29. Prehn JL, Thomas LS, Landers CJ, Yu QT, Michelsen KS, Targan SR. The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. J Immunol. 2007;178:4033-4038.
30. Chinnaiyan AM, O'Rourke K, Yu GL, et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science. 1996;274:990-992.
31. Screaton GR, Xu XN, Olsen AL, et al. LARD: a new lymphoid-specifc death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci \USA. 1997;94:4615-4619.
32. Al-Lamki RS, Wang J, Thiru S, et al. Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants. Am J Pathol. 2003;163:401-411.
33. Papadakis KA, Prehn JL, Landers C, et al. TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells. J Immunol. 2004;172:7002-7007.
34. Yang CR, Hsieh SL, Teng CM, Ho FM, Su WL, Lin WW. Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, acytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action. Cancer Res. 2004;64:1122-1129.
35. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer. 2002;2:420-430.
36. Takedatsu H, Michelsen KS, Wei B, et al. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology. 2008;135:552-567.
37. Bull MJ, Williams AS, Mecklenburgh Z, et al. The death receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in infammatory arthritis. J Exp Med. 2008;205:2457-2464.
38. Bamias G, Siakavellas SI, Stamatelopoulos KS, Chryssochoou E, Papamichael C, Sfkakis PP. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin Immunol. 2008;129:249-255.
39. Fang L, Adkins B, Deyev V, Podack ER. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung infammation. J Exp Med. 2008;205:1037-1048.
40. Meylan F, Davidson TS, Kahle E, et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated infammatory diseases. Immunity. 2008;29:79-89.
41. Pappu BP, Borodovsky A, Zheng TS, et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J Exp Med. 2008;205:1049-1062.
42. Kim SH, Lee WH, Kwon BS, Oh GT, Choi YH, Park JE. Tumor necrosis factor receptor superfamily 12 may destabilize atherosclerotic plaques by inducing matrix metalloproteinases. Jpn Circ J. 2001;65:136-138.
43. Kim WJ, Kang YJ, Suk K, Park JE, Kwon BS, Lee WH. Comparative analysis of the expression patterns of various TNFSF/TNFRSF in atherosclerotic plaques. Immunol Invest. 2008;37:359-373.
44. Wick G, Knofach M, Xu Q. Autoimmune and infammatory mechanisms in atherosclerosis. Annu Rev Immunol. 2004;22:361-403.
45. Hampel B, Fortschegger K, Ressler S, et al. Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence. Exp Gerontol. 2006;41:474-481.
46. Untergasser G, Koeck R, Wolf D, et al. CD34+/CD133-circulating endothelial precursor cells (CEP): characterization, senescence and in vivo application. Exp Gerontol. 2006;41:600-608.
47. Unterluggauer H, Hampel B, Zwerschke W, Jansen-Durr P. Senescence-associated cell death of human endothelial cells: the role of oxidative stress. Exp Gerontol. 2003;38:1149-1160.
48. Pfaff MW A new mathematical model for relative quantifcation in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
49. Rainer J, Sanchez-Cabo F, Stocker G, Sturn A, Trajanoski Z. CARMAweb: comprehensive R-and bioconductor-based web service for microarray data analysis. Nucleic Acids Res. 2006;34:W498-W503.
50. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3:745-756.
51. Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med. 2008;29:258-289.
52. Vincent B, Paitel E, Saftig P, et al. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem. 2001;276: 37743-37746.
53. Althoff K, Mullberg J, Aasland D, et al. Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. Biochem J. 2001;353:663-672.
54. Zhang Z, Oliver P, Lancaster JJ, et al. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ect-odomain shedding induced by phorbol myristate acetate. FASEB J. 2001;15:303-305.
55. Kim S, Zhang L. Identifcation of naturally secreted soluble form of TL1A, a TNF-like cytokine. J Immunol Methods. 2005;298:1-8.
56. Wagner M, Hampel B, Bernhard D, Hala M, Zwerschke W, Jansen-Durr P. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp Gerontol. 2001;36:1327-1347.
57. Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N. Angiogenesis assays: a critical overview. Clin Chem. 2003;49:32-40.
58. Yao JJ, Zhang M, Miao XH, et al. Isoform of vascular endothelial cell growth inhibitor (VEGI72-251) increases interleukin-2 production by activation of T lymphocytes. Acta Biochim Biophys Sin (Shanghai). 2006;38:249-253.
59. Yue TL, Ni J, Romanic AM, et al. TL1, a novel tumor necrosis factorlike cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease. J Biol Chem. 1999;274:1479-1486.
60. Wang L, Pan W, Zhu FL, et al. Cloning, expression and biological activity of VEGI(151), a novel vascular endothelial cell growth inhibitor. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2000;32: 485-489.
61. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
62. Siebert PD, Chenchik A. Modifed acid guanidinium thiocyanate-phenol- chloroform RNA extraction method which greatly reduces DNA contamination. Nucleic Acids Res. 1993;21:2019-2020.
63. De Matteis MA, Luini A. Exiting the Golgi complex. Nat Rev Mol Cell Biol. 2008;9:273-284.
64. Dernbach E, Urbich C, Brandes RP, Hofmann WK, Zeiher AM, Dimmeler S. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood. 2004;104:3591-3597.
65. Wen L, Zhuang L, Luo X, Wei P. TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. J Biol Chem. 2003;278:39251-39258.
66. Su WB, Chang YH, Lin WW, Hsieh SL. Differential regulation of interleukin-8 gene transcription by death receptor 3 (DR3) and type I TNF receptor (TNFRI). Exp Cell Res. 2006;312:266-277.
67. Ruegg C, Hasmim M, Lejeune FJ, Alghisi GC. Antiangiogenic peptides and proteins: from experimental tools to clinical drugs. Biochim Biophys Acta. 2006;1765:155-177.
68. Yu J, Tian S, Metheny-Barlow L, et al. Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor. Circ Res. 2001;89:1161-1167.
69. Haridas V, Shrivastava A, Su J, et al. VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth. Oncogene. 1999;18:6496-6504.
70. Zhang M, Wang L, Wang HW, Pan X, Pan W, Qi ZT. [Effect of N-terminal deletion on biological activity of vascular endothelial cell growth inhibitor]. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003;35:133-137.